AdAlta (1AD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period East Meets West: AdAlta navigates China–US divide to drive biotech valueApril 21, 2025 | msn.comHealth Kick Podcast: Deep dive into AdAlta’s East to West strategyApril 9, 2025 | msn.comClosing Bell: ASX up 1.2pc with power play from tech stocks, surprise dip in jobsMarch 20, 2025 | msn.comStockTake: AdAlta subsidiary AdCella secures funding boostMarch 19, 2025 | msn.comAdAlta Secures Investment to Accelerate ‘East to West’ Immunotherapy StrategyMarch 19, 2025 | tipranks.comAdAlta Limited Issues New Shares to Strengthen FundingMarch 16, 2025 | tipranks.comAdAlta to Showcase ‘East to West’ Strategy at Biopharma SummitMarch 3, 2025 | tipranks.comAdAlta Limited Reports Significant Revenue Decline in H1 2024February 20, 2025 | tipranks.comLong Shortz with AdAlta: The East to West vision for immunotherapyFebruary 10, 2025 | msn.comAdAlta Issues New Shares to Employees Under Equity PlanFebruary 6, 2025 | tipranks.comAdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationFebruary 6, 2025 | msn.com'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ditched AD-214February 5, 2025 | msn.comAdAlta Limited Unveils Strategic ‘East to West’ Cellular Immunotherapy ApproachFebruary 5, 2025 | tipranks.comRoad to 2025: AdAlta’s push to advance lead drug AD-214 for deadly IPFJanuary 7, 2025 | msn.comInsider Traders Lose AU$43k As AdAlta DropsDecember 20, 2024 | uk.finance.yahoo.comWTF with 1AD: New approach to treating fibrosis with lead i-body drug candidateNovember 24, 2024 | msn.comAdAlta Limited Advances Drug Discovery and PartnershipsNovember 21, 2024 | markets.businessinsider.comAdAlta Ltd. Showcases Drug Development ProspectsNovember 21, 2024 | markets.businessinsider.comAdAlta Strengthens Board with New AppointmentsNovember 17, 2024 | markets.businessinsider.comAdAlta to Showcase Innovative Drug Discovery at TSN ConferenceOctober 30, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Growing in confidence every day for fibrotic medical treatmentsOctober 28, 2024 | msn.comAdAlta Limited Strengthens Clinical and Strategic InitiativesOctober 24, 2024 | markets.businessinsider.comAdAlta secures top talent to lead AdCella and AdSolis as boost in clinical activity loomsOctober 23, 2024 | msn.comClosing Bell: WiseTech drags again; 29Metals sinks 20pc on copper outputOctober 23, 2024 | msn.comAdAlta Strengthens Leadership for Cancer and Fibrosis TherapiesOctober 23, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Global health experts recruited for idiopathic pulmonary fibrosis drugOctober 10, 2024 | msn.comAdAlta forms clinical advisory board to advance IPF drug candidateOctober 9, 2024 | msn.comUp 19% in 2024, is it time to buy or sell Coles shares?September 18, 2024 | fool.com.auClosing Bell: ASX up 0.22pc after slow start; iron ore miners, REA weigh on marketSeptember 2, 2024 | msn.comHealth Kick Podcast: Creating hope for debilitating diseasesAugust 27, 2024 | msn.comLong Shortz with AdAlta: New quarter, twice the cashAugust 1, 2024 | msn.comAdAlta Ltd 1ADMay 17, 2024 | morningstar.comLong Shortz with AdAlta: Progressive partnership to spread life-saving immunotherapiesMay 14, 2024 | msn.comMarket Highlights: Novovax doubles; Chalmers calls critical minerals a ‘golden opportunity’May 13, 2024 | msn.comAdAlta secures Cell Therapies as cellular immunotherapies manufacturerMay 13, 2024 | msn.comAdAlta locks in $3.7m to speed up Phase II clinical trials, near-term partnershipsApril 29, 2024 | msn.comLong Shortz with AdAlta: Strengthening bonds in the fight against cancerApril 8, 2024 | msn.comAdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapyApril 7, 2024 | msn.comAdAlta delivers positive Phase I Extension Study results for AD-214March 8, 2024 | finance.yahoo.comScoPo’s (actually Wilkie’s) Powerplays: Health stocks rise as AdAlta soars 17% on trial resultsMarch 8, 2024 | msn.comLeeds - Weather warnings issuedFebruary 15, 2024 | bbc.comCountdown on to AdAlta trial results as biotech advances partner discussionsFebruary 11, 2024 | msn.comAdAlta Insiders Placed Bullish Bets Worth AU$850.2kFebruary 4, 2024 | finance.yahoo.comAdAlta advancing partnering programs as AD-214 participants receive final doseJanuary 22, 2024 | msn.comAdalta Ltd (1AD)January 9, 2024 | es.investing.comWhat’s in store for 2024: AdAltaJanuary 4, 2024 | msn.comMoney Talks: Keep an eye on these tasty precious metal and biotech plays in 2024December 28, 2023 | msn.comLong Shortz with AdAlta: How the company has potentially broken the malaria life cycleDecember 19, 2023 | msn.com‘World first’: AdAlta’s i-body platform a breakthrough for malaria treatmentDecember 18, 2023 | msn.comAdAlta on track for trial readout in Q1 2024 after $1.65m cap raiseDecember 13, 2023 | msn.com Get AdAlta News Delivered to You Automatically Sign up to receive the latest news and ratings for 1AD and its competitors with MarketBeat's FREE daily newsletter. Email Address 1AD Media Mentions By Week 1AD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. 1AD News Sentiment▼0.000.86▲Average Medical News Sentiment 1AD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. 1AD Articles This Week▼10▲1AD Articles Average Week Get AdAlta News Delivered to You Automatically Sign up to receive the latest news and ratings for 1AD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:1AD) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYou’re About to Lose Everything – Act Now or Regret It ForeverWhat If America's Gold Reserves Are a Lie? For decades, the U.S. government has claimed to have thousands o...Hamilton Gold Group | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdAlta Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share AdAlta With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy 1AD Stock Free 1AD Stock Alerts